![](http://www.bbpharmaco.com/mwp/wp-content/themes/mandegar/img/banner-products.jpg)
Gastro intestinal
Pantobiozole®
Brand Name:
Pantobiozole ®
Dosage:
20 mg & 40 mg
Generic Name:
Pantoprazole
Pharmacotherapeutic Group:
Antiulcerants
Therapeutic Indication:
Pantoprazole: Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD)
Maintenance of Healing of Erosive Esophagitis
Zollinger-Ellison Syndrome
Dosage and Administration:
The recommended adult oral dose is 40 mg given once daily for up to 8 weeks. For those patients who have not healed after 8 weeks of treatment, an additional 8-week course of Pantobiozole may be considered.
Side Effects:
- As a general adverse reaction related to drug occurred in 1% or more are:
- Headache, Diarrhea, Flatulence, Abdominal pain, Eructation, Hyperglycemia